Apexium Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
5,598
-50
| -0.9% | -$9.28K | 0.06% | 125 |
|
|
2025
Q1 | $1.18M | Buy |
5,648
+1,680
| +42% | +$352K | 0.07% | 110 |
|
|
2024
Q4 | $705K | Buy |
3,968
+728
| +22% | +$129K | 0.04% | 134 |
|
|
2024
Q3 | $640K | Buy |
3,240
+663
| +26% | +$131K | 0.04% | 123 |
|
|
2024
Q2 | $442K | Buy |
2,577
+74
| +3% | +$12.7K | 0.03% | 145 |
|
|
2024
Q1 | $456K | Sell |
2,503
-183
| -7% | -$33.3K | 0.03% | 148 |
|
|
2023
Q4 | $416K | Buy |
2,686
+659
| +33% | +$102K | 0.03% | 189 |
|
|
2023
Q3 | $302K | Buy |
2,027
+37
| +2% | +$5.52K | 0.03% | 171 |
|
|
2023
Q2 | $268K | Sell |
1,990
-13
| -0.6% | -$1.75K | 0.02% | 186 |
|
|
2023
Q1 | $319K | Sell |
2,003
-24
| -1% | -$3.83K | 0.03% | 170 |
|
|
2022
Q4 | $328K | Buy |
2,027
+1
| +0% | +$162 | 0.03% | 158 |
|
|
2022
Q3 | $272K | Buy |
+2,026
| New | +$272K | 0.03% | 161 |
|